Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02874196
Other study ID # 2011-A00677-34
Secondary ID
Status Completed
Phase N/A
First received August 17, 2016
Last updated August 17, 2016
Start date July 2012
Est. completion date September 2015

Study information

Verified date August 2016
Source Central Hospital, Nancy, France
Contact n/a
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

The purpose is to determine diagnostic performances of flat panel dual energy arthrography and arthro-tomosynthesis in identification of loosening of painful hip prosthesis, taking as reference the results of surgery performed 6 months after arthrography.

Secondary purposes are:

- To describe the level of concordance of each technique with the indication for surgery

- To study inter-technique concordance with kappa coefficient

- To study the relationship between density differential between 2 acquisitions and grey level on subtraction, i.e. subtraction quality according to metal


Description:

Hip arthroplasty has become one of the most performed orthopedic procedures. Actual average lifetime of total hip prosthesis is approximately 15 years. Some complications are inevitable. Total hip prosthesis imaging, performed to search for a complication or wear, is difficult and depends on many techniques. Subtracted arthrography is a good technique but its access is limited because it needs an angiography room.

In this study patients undergo standard arthrography, dual energy arthrography, arthro-tomosynthesis and arthro-tomography.


Recruitment information / eligibility

Status Completed
Enrollment 66
Est. completion date September 2015
Est. primary completion date September 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients sent for arthro-tomography of painful prosthesis, without contraindications to arthrography or injection of contrast agent

- Aware and cooperative

- Signed informed consent

- Affiliation to social security

Exclusion Criteria:

- Any contraindication to arthrography or injection of contrast agent

- Pregnant or possibly pregnant women

- Patient under guardianship

- Refusal or impossibility of informed consent

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Procedure:
Standard arthrography

Dual energy arthrography

Arthro-tomosynthesis

Arthro-tomography

Surgery on painful prosthesis
Possibly performed during 6 months from arthrography

Locations

Country Name City State
France CHU de Nancy Nancy
France SINCAL Nancy

Sponsors (1)

Lead Sponsor Collaborator
Central Hospital, Nancy, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Presence or absence of prosthesis loosening detected with 3 radiographic techniques (dual-energy arthrography, arthro-tomosynthesis and single-energy tomography) and surgery Gold standard is presence or absence of prosthesis loosening revealed with surgery performed after 6 months from arthrography.
Data of patients undergone surgery and not are collected and analyzed. Any clinical or imagery sign of loosening in non-operated patient, will be classified as loosening. A surgery decision for suspicion of loosening will be considered loosening.
from day 0 up to 6 months No
Secondary Comparison between density differential between 2 acquisitions and grey level on subtraction day 0 No